Free Trial

Vanguard Group Inc. Sells 1,164,585 Shares of Nu Skin Enterprises, Inc. (NYSE:NUS)

Nu Skin Enterprises logo with Consumer Staples background

Vanguard Group Inc. cut its holdings in shares of Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 22.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,940,071 shares of the company's stock after selling 1,164,585 shares during the period. Vanguard Group Inc. owned approximately 7.93% of Nu Skin Enterprises worth $27,147,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. lifted its position in Nu Skin Enterprises by 175.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 231,957 shares of the company's stock worth $1,710,000 after buying an additional 147,784 shares in the last quarter. AlphaQuest LLC raised its stake in shares of Nu Skin Enterprises by 197.8% during the 4th quarter. AlphaQuest LLC now owns 108,204 shares of the company's stock worth $746,000 after purchasing an additional 71,864 shares in the last quarter. Barclays PLC lifted its holdings in shares of Nu Skin Enterprises by 363.8% during the 3rd quarter. Barclays PLC now owns 85,437 shares of the company's stock valued at $629,000 after buying an additional 67,016 shares during the last quarter. Rhumbline Advisers grew its stake in shares of Nu Skin Enterprises by 70.9% in the 4th quarter. Rhumbline Advisers now owns 138,477 shares of the company's stock valued at $954,000 after buying an additional 57,443 shares in the last quarter. Finally, American Century Companies Inc. increased its holdings in Nu Skin Enterprises by 12.0% in the fourth quarter. American Century Companies Inc. now owns 824,739 shares of the company's stock worth $5,682,000 after buying an additional 88,181 shares during the last quarter. 82.84% of the stock is currently owned by institutional investors.

Nu Skin Enterprises Stock Performance

Shares of NUS stock traded down $0.12 during trading on Friday, reaching $5.50. The company had a trading volume of 746,709 shares, compared to its average volume of 835,648. The firm's 50 day simple moving average is $7.21 and its two-hundred day simple moving average is $6.98. Nu Skin Enterprises, Inc. has a one year low of $5.35 and a one year high of $14.00. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.82 and a quick ratio of 1.17. The company has a market capitalization of $273.23 million, a PE ratio of -1.86 and a beta of 1.10.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last issued its quarterly earnings data on Thursday, February 13th. The company reported $0.38 earnings per share for the quarter, topping analysts' consensus estimates of $0.24 by $0.14. The business had revenue of $445.55 million during the quarter, compared to analysts' expectations of $441.10 million. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. Sell-side analysts forecast that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current year.

Nu Skin Enterprises Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 5th. Shareholders of record on Monday, February 24th were issued a dividend of $0.06 per share. This represents a $0.24 dividend on an annualized basis and a yield of 4.37%. The ex-dividend date was Monday, February 24th. Nu Skin Enterprises's dividend payout ratio (DPR) is -8.14%.

Wall Street Analyst Weigh In

A number of research firms have issued reports on NUS. StockNews.com cut shares of Nu Skin Enterprises from a "buy" rating to a "hold" rating in a research note on Tuesday, April 8th. DA Davidson decreased their price objective on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a "neutral" rating for the company in a report on Friday, December 20th.

Get Our Latest Stock Report on NUS

Nu Skin Enterprises Profile

(Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

Featured Articles

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Should You Invest $1,000 in Nu Skin Enterprises Right Now?

Before you consider Nu Skin Enterprises, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.

While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Sectors With Massive Momentum You Can’t Afford to Miss
Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines